Page last updated: 2024-08-25

sofosbuvir and Diffuse Parenchymal Lung Disease

sofosbuvir has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Inoue, J; Iwata, T; Kakazu, E; Masamune, A; Ninomiya, M; Sano, A; Sato, K; Tsuruoka, M1

Other Studies

1 other study(ies) available for sofosbuvir and Diffuse Parenchymal Lung Disease

ArticleYear
Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia.
    Clinical journal of gastroenterology, 2021, Volume: 14, Issue:4

    Topics: Aged; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Lung Diseases, Interstitial; Sofosbuvir; Symptom Flare Up

2021